CTI BioPharma Corp.

NASDAQ: CTIC · Real-Time Price · USD
9.10
0.01 (0.11%)
At close: Jun 23, 2023, 9:58 PM

CTI BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-92.99M -97.91M
Depreciation & Amortization
1.95M 526K
Stock-Based Compensation
10.03M 4.74M
Other Working Capital
464K 2.28M
Other Non-Cash Items
7.74M -113K
Deferred Income Tax
n/a n/a
Change in Working Capital
-7.92M 7.86M
Operating Cash Flow
-81.19M -84.89M
Capital Expenditures
-25M n/a
Cash Acquisitions
25M n/a
Purchase of Investments
-88.85M n/a
Sales Maturities Of Investments
40M 12M
Other Investing Acitivies
-25M n/a
Investing Cash Flow
-73.85M 12M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
120.02M 97.94M
Financial Cash Flow
120.02M 97.94M
Net Cash Flow
-35.03M 25.05M
Free Cash Flow
-106.19M -84.89M